IP Library › Granted Patent US 11,726,023
Granted Patent B2
US 11,726,023 · App. 17/727,879 · Granted Aug 15, 2023

Compositions and methods for cell-like calibration particles

Inventors: Jeffrey Kim (Berkeley, CA); Anh Tuan Nguyen (San Francisco, CA); Brandon Miller (Oakland, CA)
Assignee: Slingshot Biosciences, Inc.
G01N15/1012G01N2015/1006G01N2015/1018
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,726,023
App. No.
17/727,879
Granted
Aug 15, 2023
Kind
B2
Abstract

A method includes calibrating a cytometric device for analysis of a target cell, by inserting, into the cytometric device, a hydrogel particle. The hydrogel particle has at least one of a background fluorescent property or a spectral property that is substantially similar to the at least one of a background fluorescent property or a spectral property of the target cell. The method also includes measuring at least one property of the hydrogel particle using the cytometric device.

Claims (38)

1. A composition, comprising:

a hydrogel particle having (1) a background fluorescent property that is substantially similar to a background fluorescent property of a target cell, and (2) a spectral property that is substantially similar to a spectral property of the target cell, the hydrogel particle including a monomer selected from hydroxyethyl methacrylate, ethyl methacrylate, 2-hydroxyethyl methacrylate (HEMA), propylene glycol methacrylate, acrylamide, N-vinylpyrrolidone (NVP), methyl methacrylate, glycidyl methacrylate, glycerol methacrylate (GMA), glycol methacrylate, ethylene glycol, fumaric acid, 2-hydroxyethyl methacrylate, hydroxyethoxyethyl methacrylate, hydroxydiethoxyethyl methacrylate, methoxyethyl methacrylate, methoxyethoxyethyl methacrylate, methoxydiethoxyethyl methacrylate, poly(ethylene glycol) methacrylate, methoxy-poly(ethylene glycol) methacrylate, methacrylic acid, sodium methacrylate, glycerol methacrylate, hydroxypropyl methacrylate, hydroxybutyl methacrylate, phenyl acrylate, phenyl methacrylate, benzyl acrylate, benzyl methacrylate, 2-phenylethyl acrylate, 2-phenylethyl methacrylate, 2-phenoxyethyl acrylate, 2-phenoxyethyl methacrylate, phenylthioethyl acrylate, phenylthioethyl methacrylate, 2,4,6-tribromophenyl acrylate, 2,4,6-tribromophenyl methacrylate, pentabromophenyl acrylate, pentabromophenyl methacrylate, pentachlorophenyl acrylate, pentachlorophenyl methacrylate, 2,3-dibromopropyl acrylate, 2,3-dibromopropyl methacrylate, 2-naphthyl acrylate, 2-naphthyl methacrylate, 4-methoxybenzyl acrylate, 4-methoxybenzyl methacrylate, 2-benzyloxyethyl acrylate, 2-benzyloxyethyl methacrylate, 4-chlorophenoxyethyl acrylate, 4-chlorophenoxyethyl methacrylate, 2-phenoxyethoxyethyl acrylate, 2-phenoxyethoxyethyl methacrylate, N-phenyl acrylamide, N-phenyl methacrylamide, N-benzyl acrylamide, N-benzyl methacrylamide, N,N-dibenzyl acrylamide, N,N-dibenzyl methacrylamide, N-diphenylmethyl acrylamide N-(4-methylphenyl)methyl acrylamide, N-1-naphthyl acrylamide, N-4-nitrophenyl acrylamide, N-(2-phenylethyl)acrylamide, N-triphenylmethyl acrylamide, N-(4-hydroxyphenyl)acrylamide, N,N-methylphenyl acrylamide, N,N-phenyl phenylethyl acrylamide, N-diphenylmethyl methacrylamide, N-(4-methyl phenyl)methyl methacrylamide, N-1-naphthyl methacrylamide, N-4-nitrophenyl methacrylamide, N-(2-phenylethyl)methacrylamide, N-triphenylmethyl methacrylamide, N-(4-hydroxyphenyl)methacrylamide, N,N-methylphenyl methacrylamide, N,N′-phenyl phenylethyl methacrylamide, N-vinyl carbazole, 4-vinylpyridine, 2-vinylpyridine, or a combination thereof.

2. The composition of claim 1 , wherein the hydrogel particle is configured to bind to an antibody that is bound to a conjugated fluorophore.

3. The composition of claim 2 , wherein the conjugated fluorophore is a fluorochrome.

4. The composition of claim 1 , wherein the hydrogel particle is a modified hydrogel particle that has been modified to bind to at least one of an intercalating nucleic acid labeling reagent or an amine-reactive labeling reagent.

5. The composition of claim 1 , wherein the hydrogel particle has a refractive index of greater than about 1.15.

6. The composition of claim 1 , wherein the hydrogel particle has a refractive index of greater than about 1.3.

7. The composition of claim 1 , wherein the hydrogel particle has a refractive index of greater than about 1.7.

8. The composition of claim 1 , wherein the hydrogel particle has a diameter of less than about 100 μm.

9. The composition of claim 1 , wherein the hydrogel particle has a diameter of less than about 10 μm.

10. The composition of claim 1 , wherein the hydrogel particle has a diameter of less than about 1 μm.

11. The composition of claim 1 , wherein the hydrogel particle contains polymer nanoparticle additives.

12. The composition of claim 1 , wherein the hydrogel particle is a chemically functionalized hydrogel particle.

13. The composition of claim 1 , wherein the hydrogel particle comprises a free amine group.

14. The composition of claim 1 , wherein the hydrogel particle comprises allylamine.

15. The composition of claim 1 , wherein the target cell is an immune cell.

16. The composition of claim 1 , wherein the hydrogel particle is a hydrogel particle that has been modified by conjugating or attaching one of a fluorophore or a fluorochrome.

17. The composition of claim 1 , wherein the hydrogel particle has been modified to match a fluorescence profile of the target cell.

18. The composition of claim 1 , wherein the at least one of the background fluorescent property or the spectral property includes one of inter-laser delay, fluorescence response, or sort timing.

19. The composition of claim 1 , wherein the target cell is a human cell.

20. A composition, comprising:

a hydrogel particle having (1) a background fluorescent property that is substantially similar to a background fluorescent property of a target cell, and (2) a spectral property that is substantially similar to a spectral property of the target cell, the hydrogel particle being a modified hydrogel particle that has been modified to bind to at least one of an intercalating nucleic acid labeling reagent or an amine-reactive labeling reagent.

21. A composition, comprising:

a hydrogel particle having (1) a background fluorescent property that is substantially similar to a background fluorescent property of a target cell, and (2) a spectral property that is substantially similar to a spectral property of the target cell, the hydrogel particle having a refractive index of greater than about 1.15.

22. A composition, comprising:

a hydrogel particle having (1) a background fluorescent property that is substantially similar to a background fluorescent property of a target cell, and (2) a spectral property that is substantially similar to a spectral property of the target cell, the hydrogel particle having a refractive index of greater than about 1.3.

23. A composition, comprising:

a hydrogel particle having (1) a background fluorescent property that is substantially similar to a background fluorescent property of a target cell, and (2) a spectral property that is substantially similar to a spectral property of the target cell, the hydrogel particle having a refractive index of greater than about 1.7.

24. A composition, comprising:

a hydrogel particle having (1) a background fluorescent property that is substantially similar to a background fluorescent property of a target cell, and (2) a spectral property that is substantially similar to a spectral property of the target cell, the hydrogel particle including a polymer nanoparticle additive.

25. A composition, comprising:

a hydrogel particle having (1) a background fluorescent property that is substantially similar to a background fluorescent property of a target cell, and (2) a spectral property that is substantially similar to a spectral property of the target cell, the hydrogel particle comprising a free amine group.

26. A composition, comprising:

a hydrogel particle having (1) a background fluorescent property that is substantially similar to a background fluorescent property of a target cell, and (2) a spectral property that is substantially similar to a spectral property of the target cell, the hydrogel particle comprising allylamine.

27. A composition, comprising:

a hydrogel particle having (1) a background fluorescent property that is substantially similar to a background fluorescent property of a target cell, and (2) a spectral property that is substantially similar to a spectral property of the target cell, the hydrogel particle being a hydrogel particle that has been modified by conjugating or attaching one of a fluorophore or a fluorochrome.

28. A composition, comprising:

a hydrogel particle having (1) a background fluorescent property that is substantially similar to a background fluorescent property of a target cell, and (2) a spectral property that is substantially similar to a spectral property of the target cell, the hydrogel particle being a hydrogel particle that has been modified to match a fluorescence profile of the target cell.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2022
From: KIM, JEFFREY; NGUYEN, ANH TUAN; MILLER, BRANDON
To: SLINGSHOT BIOSCIENCES, INC.
Reel/Frame 059798/0499 →
Continuity (3)
Continuation 17155294 · Jan 22, 2021
Provisional Application 62965494 · Jan 24, 2020
Related Publication 20220364976A1 · Nov 17, 2022
Cited By (9)
US 12,196,661 US 12,228,492 US 12,276,659 US 12,312,595 US 12,332,241 US 12,352,679 US 12,379,387 US 12,461,007 US 12,669,427